DuPont puts medical products businesses on the market
This article was originally published in Clinica
Executive Summary
US chemicals group DuPont wants to exit the medical devices sector, following in the footsteps of Eli Lilly. DuPont has put its four medical products businesses up for sale to part-finance $8,800 million share purchase from Seagram in April. DuPont had indicated before that it would sell about $2,000 million worth of assets to this end. The sale does not include DuPont's half share in DuPont Merck Pharmaceutical.